Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine crawled date : 2021 - 03 - 12 save search
Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization
Published: 2021-03-12 (Crawled : 17:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.09%
H: 0.65%
C: 0.2%
covid vaccine merge granted grant
Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology
Published: 2021-03-12 (Crawled : 17:00) - biospace.com/
ANIX | $3.04 -2.56% -2.63% 58K
|
Health Technology
|
| O: 30.51%
H: 2.12%
C: -12.94%
cancer vaccine patent ovarian cancer bioscience
Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization
Published: 2021-03-12 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.09%
H: 0.65%
C: 0.2%
covid vaccine merge granted grant
COVID-19 Vaccine News: Novavax Effective Against Variants; Sanofi/Translate Begin Early Trials
Published: 2021-03-12 (Crawled : 16:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.06%
H: 0.48%
C: 0.42%
covid vaccine trial covid-19
AccuShelf® Integrates COVID-19 Specific Vaccine Workflows to Help Healthcare Comply With COVID-19 Vaccine Storage and Tracking
Published: 2021-03-12 (Crawled : 15:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.09%
H: 0.65%
C: 0.2%
covid vaccine covid-19
COVID-19 Vaccine News: Novavax Effective Against Variants; Sanofi/Translate B...
Published: 2021-03-12 (Crawled : 15:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.06%
H: 0.48%
C: 0.42%
covid vaccine covid-19
Thanks to Accelerated COVID-19 Research, New Therapeutic Vaccines May Soon Be Upon Us
Published: 2021-03-12 (Crawled : 14:21) - prnewswire.com
MRK | $126.94 0.92% 0.0% 7.8M
|
Health Technology
|
| O: -0.8%
H: 1.16%
C: 0.77%
REGN | News | $899.71 0.32% 0.32% 340K
|
Health Technology
|
| O: -0.63%
H: 1.03%
C: 0.96%
MRNA | News S | $104.48 3.03% 2.94% 3.1M
|
Health Technology
|
| O: -4.58%
H: 3.51%
C: 2.2%
BNTX | News | $88.01 1.38% 1.36% 390K
|
Health Technology
|
| O: -3.18%
H: 3.97%
C: 3.97%
covid vaccine research covid-19
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate
Published: 2021-03-12 (Crawled : 07:00) - globenewswire.com
TBIO | $0.33 6.8% 6.36% 69K
|
Health Technology
|
| O: 4.53%
H: 0.91%
C: -2.26%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.06%
H: 0.48%
C: 0.42%
covid phase 1 vaccine trial phase 3 phase 2 covid-19
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.